title: Renal crystal formation after combined or sequential oral administration of melamine and cyanuric acid.
abstract: We evaluated renal melamine-cyanurate crystal spherulite formation after single and repeated ingestion of both melamine (MEL) and cyanuric acid (CYA) in catfish and trout. MEL and CYA were co-administered orally over a range of doses, 0.1-20mg/kg body weight (bw) of each compound, either once or repeatedly for 4, 14 or 28 days (d). In catfish, the No Observable Adverse Effects Levels (NOAELs) for crystal formation for single, 4d or 14 d dosing were 10, 2.5 and 0.5mg/kg bw, respectively. In trout, the respective NOAELs were 2.5, 2.5 and 0.5mg/kg bw. No renal crystals formed in catfish fed 0.1mg/kg bw of each compound for 28 d. Sequential administration of 20mg/kg bw of MEL followed by 20mg/kg bw of CYA or vise-versa, with waiting periods of 1, 3, 7, 14 or 21 d between compound dosing also induced renal crystal formation in fish. These studies show that both catfish and trout are sensitive, non-mammalian models, for renal crystal formation following MEL and CYA ingestion. Since fish generally excrete chemicals more slowly than mammals, they may provide a "worst case scenario" model for higher risk populations, such as infants or persons with compromised renal function.
authors.affiliation: Center for Veterinary Medicine, US Food and Drug Administration, 8401 Muirkirk Rd, Laurel, MD 20708, USA. Renate.reimschuessel@fda.hhs.gov
authors.forename: R
authors.initials: R
authors.lastname: Reimschuessel
authors.forename: E R
authors.initials: ER
authors.lastname: Evans
authors.forename: C B
authors.initials: CB
authors.lastname: Stine
authors.forename: N
authors.initials: N
authors.lastname: Hasbrouck
authors.forename: T D
authors.initials: TD
authors.lastname: Mayer
authors.forename: C
authors.initials: C
authors.lastname: Nochetto
authors.forename: C M
authors.initials: CM
authors.lastname: Gieseker
mesh_terms: D000818:Animals; D003460:Crystallization; D005506:Food Contamination; D007059:Ictaluridae; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology*; D007677:Kidney Function Tests; D019055:No-Observed-Adverse-Effect Level; D017686:Oncorhynchus mykiss; D014227:Triazines / Q000008:administration & dosage / Q000633:toxicity*
chemical_list: D014227:Triazines; C004632:cyanuric acid; C011907:melamine